Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
Klabunde, T., Wendt, K.U., Kadereit, D., Brachvogel, V., Burger, H.J., Herling, A.W., Oikonomakos, N.G., Kosmopoulou, M.N., Schmoll, D., Sarubbi, E., von Roedern, E., Defossa, E.(2005) J.Med.Chem. 48: 6178-6193
- PubMed: 16190745 
- DOI: 10.1021/jm049034y
- Also Cited By: 1WV1, 1WV0, 1WUY
- PubMed Abstract: 
Using a focused screening approach, acyl ureas have been discovered as a new class of inhibitors of human liver glycogen phosphorylase (hlGPa). The X-ray structure of screening hit 1 (IC50 = 2 microM) in a complex with rabbit muscle glycogen phosphor ...